Cannabis Report
Lithium
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, NASDAQ2020, IB_, namtae, Chasing
Search This Board: 
Last Post: 8/18/2018 11:18:55 PM - Followers: 842 - Board type: Free - Posts Today: 63

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


Cannabis Report
Lithium
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 08/14/2018 01:21:34 PM
ELTP News: Current Report Filing (8-k) 08/09/2018 04:59:48 PM
ELTP News: Quarterly Report (10-q) 08/09/2018 04:36:07 PM
ELTP News: Current Report Filing (8-k) 08/07/2018 04:03:56 PM
ELTP News: Current Report Filing (8-k) 08/06/2018 04:17:55 PM
PlusOneCoin Top Posts
#298441   1. SunGen ANDA #2-THE MONSTER $1.6 Billion dollar NASDAQ2020 08/17/18 06:14:04 PM
#298403  Restored Based on what? reaper247 08/17/18 12:10:05 AM
PostSubject
#297872  Sticky Note Transcript for August 10, 2018 Conference Call: rrr2003 08/11/18 12:23:56 AM
#296577  Sticky Note $ELTP-(CHART)-GOLDEN-CROSS-on-the-MOUNTAIN-of-GREATNESS-Running-the-POWERZONE!!! Drugdoctor 08/04/18 10:15:24 AM
#295013  Sticky Note Elites 2018-2019 DollarLand Catalysts NASDAQ2020 07/19/18 02:24:31 PM
#288420  Sticky Note He cherry picked certain parts of the CRL stockboy 04/26/18 12:58:32 AM
#285485  Sticky Note I think you said in the past that no2koolaid 03/10/18 02:20:10 PM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#298525   During a CC in 2013 or 2014 Nasrat aELmTPa 08/18/18 11:18:54 PM
#298524   Who cares? I have 2 bosses heavily involved jour_trader 08/18/18 11:09:29 PM
#298523   PLD Acquisitions NASDAQ2020 08/18/18 11:08:45 PM
#298522   Looks like something big is about to happen soon. aELmTPa 08/18/18 11:03:44 PM
#298521   Perhaps some one could post the m&a desks dr_lowenstein 08/18/18 10:11:56 PM
#298518   he doesnt know anything about M&A.. sorry dr_lowenstein 08/18/18 09:59:36 PM
#298517   Ask Aqeel. NASDAQ2020 08/18/18 09:39:04 PM
#298516   True that snup. China will save their 1 kennyt 335 08/18/18 08:46:40 PM
#298515   but no chatter from any experts in the field dr_lowenstein 08/18/18 08:38:56 PM
#298514   Excitement is right! Per the end of the conference Hutch321 08/18/18 08:12:58 PM
#298513   Wonder if he's hinting at something. aELmTPa 08/18/18 07:53:15 PM
#298512   Competitors for the Elite’s Massive Revenue Generating Products NASDAQ2020 08/18/18 07:50:02 PM
#298511   Chatter on this board doesn’t count. At. All. Lol jour_trader 08/18/18 07:10:55 PM
#298510   M&A chatter at an all time high . NASDAQ2020 08/18/18 07:04:19 PM
#298509   MORE BS as they won't get approval from stockboy 08/18/18 04:12:50 PM
#298508   Maybe Elite should check out Venus or Jupiter namtae 08/18/18 03:57:28 PM
#298507   Elite may go China route if fda keeps snupoled 08/18/18 03:55:09 PM
#298506   How long have we been saying Sequest is namtae 08/18/18 03:29:46 PM
#298505   You're right good thing they branching into every stockboy 08/18/18 03:08:17 PM
#298504   no one added that has real M&A background, sorry dr_lowenstein 08/18/18 03:01:07 PM
#298503   Overtime companies need to refresh their BOD as jour_trader 08/18/18 02:30:55 PM
#298499   i guess i should luvwetscent 08/18/18 01:24:41 PM
#298497   The CEO admitted the FDA told him Sequest namtae 08/18/18 12:53:25 PM
#298496   FDA told NH SequestOx Tmax problems originally nothing dr_lowenstein 08/18/18 12:44:41 PM
#298495   More BS namtae 08/18/18 12:28:40 PM
#298494   If you look at Level II there is jour_trader 08/18/18 12:17:27 PM
#298493   Link what are you talking about see nothing rocioyogi 08/18/18 11:52:00 AM
#298492   There is lots of info about Sequest that namtae 08/18/18 11:32:16 AM
#298491   Look at that .1250 ask!!!!!!!!!!!!!!! kennyt 335 08/18/18 11:29:05 AM
#298490   So what namtae 08/18/18 11:29:02 AM
#298489   Was it an OTC stock? Private or public? stockboy 08/18/18 11:18:14 AM
#298488   Receiving company stock as an incentive to the Jimmy Joe 08/18/18 11:13:59 AM
#298487   Highly recommend Glass Door for any reviews of Jimmy Joe 08/18/18 10:53:46 AM
#298486   Elites shares did break under 11 and have namtae 08/18/18 10:17:15 AM
#298485   WOW Elite Pharma Company Reviews namtae 08/18/18 10:15:26 AM
#298484   Whatever you say. Jimmy Joe 08/18/18 10:13:47 AM
#298483   What can be derived from those "reviews" and Jimmy Joe 08/18/18 10:12:01 AM
#298482   Laughable They brought him on board for a reason namtae 08/18/18 10:11:42 AM
#298481   Took Pfeiffer's place. Jimmy Joe 08/18/18 09:56:31 AM
#298480   Let's try this again...…. Jimmy Joe 08/18/18 09:50:46 AM
#298479   Lol Depends on when their board meetings are held. jour_trader 08/18/18 09:16:16 AM
#298478   That's a nice dream won't do much for stockboy 08/18/18 08:07:49 AM
#298477   MORE LIKE DEADLIER THAN OXYCONTIN! Do you have stockboy 08/18/18 08:05:09 AM
#298476   FDA will UNLEASH the KRAKEN KILLER CRL's soon. stockboy 08/18/18 08:02:46 AM
#298475   PLEASE PROVIDE A FORM 4 for evidence or stockboy 08/18/18 08:00:02 AM
#298474   Reformulated Patent Pending SequestOx™ is the SAFEST IR NASDAQ2020 08/18/18 07:33:09 AM
#298473   Elites 2018-2019 LineUp NASDAQ2020 08/18/18 07:31:15 AM
#298472   Insiders Accumulating Shares. NASDAQ2020 08/18/18 07:27:06 AM
#298471   So far that insight hasn't helped anyoneby connecting stockboy 08/18/18 06:29:05 AM
#298470   I doubt he'll add any value 111 days stockboy 08/18/18 06:27:15 AM
PostSubject